ADVANCED VAGINAL ADENOSQUAMOUS CARCINOMA
Clinical trials for ADVANCED VAGINAL ADENOSQUAMOUS CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED VAGINAL ADENOSQUAMOUS CARCINOMA trials appear
Sign up with your email to follow new studies for ADVANCED VAGINAL ADENOSQUAMOUS CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a drug combo boost survival in advanced cervical cancer?
Disease control OngoingThis study tests whether adding the drug triapine to standard radiation and chemotherapy (cisplatin) helps women with advanced cervical or vaginal cancer live longer. About 450 women with newly diagnosed, bulky stage IB2 to IVA cervical cancer or stage II-IVA vaginal cancer will …
Matched conditions: ADVANCED VAGINAL ADENOSQUAMOUS CARCINOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 11:58 UTC
-
New drug combo shows promise in advanced cervical and vaginal cancer trial
Disease control OngoingThis early-phase trial tested the safety and best dose of an oral drug called triapine when added to standard chemoradiation (cisplatin + radiation) for people with advanced cervical or vaginal cancer. Twenty-one participants received the combination to see how well it was tolera…
Matched conditions: ADVANCED VAGINAL ADENOSQUAMOUS CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 04, 2026 16:23 UTC